$CTOS
Custom Truck One Source, Inc. Stock $ctos

$ctos Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000170968223000048 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$434.4M	$456.8M	$362.1M
YoY Change	21.4%	26.16%	-3.47%
Cost Of Revenue	$327.2M	$346.2M	$279.3M
YoY Change	21.36%	23.94%	-14.94%
Gross Profit	$107.2M	$110.6M	$82.76M
YoY Change	21.53%	33.67%	77.25%
Gross Profit Margin	24.67%	24.21%	22.85%
Selling, General & Admin	$56.96M	$58.03M	$48.78M
YoY Change	14.29%	18.96%	-4.85%
% of Gross Profit	53.15%	52.46%	58.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$54.60M	$55.44M	$54.62M
YoY Change	1.11%	1.5%	-10.61%
% of Gross Profit	50.95%	50.12%	66.0%
Operating Expenses	$69.15M	$71.04M	$57.97M
YoY Change	6.27%	22.56%	-35.68%
Operating Profit	$38.01M	$39.58M	$24.79M
YoY Change	64.5%	59.63%	-157.08%
Interest Expense	-$34.14M	-$31.63M	-$20.28M
YoY Change	49.19%	55.93%	2.83%
% of Operating Profit	-89.83%	-79.91%	-81.81%
Other Income/Expense, Net	-$28.40M	-$26.58M	$15.08M
YoY Change	34.34%	-276.26%	-119.0%
Pretax Income	$9.612M	$13.00M	$13.54M
YoY Change	388.66%	-4.02%	-111.03%
Income Tax	$432.0K	$1.388M	-$81.00K
% Of Pretax Income	4.49%	10.68%	-0.6%
Net Earnings	$9.180M	$11.61M	$13.62M
YoY Change	-485.39%	-14.78%	-110.53%
Net Earnings / Revenue	2.11%	2.54%	3.76%
Basic Earnings Per Share	$0.04	$0.05	$0.05
Diluted Earnings Per Share	$0.04	$0.05	$54.80K
COMMON SHARES
Basic Shares Outstanding	246.3M shares	246.1M shares	247.6M shares
Diluted Shares Outstanding	246.6M shares	247.0M shares	248.6M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.800M	$42.23M	$28.52M
YoY Change	-66.38%	48.05%	4.83%
Cash & Equivalents	$8.793M	$42.23M	$28.52M
Short-Term Investments
Other Short-Term Assets	$21.00M	$27.59M	$13.80M
YoY Change	110.23%	99.91%	-11.76%
Inventory	$888.8M	$765.4M	$536.1M
Prepaid Expenses
Receivables	$156.3M	$152.0M	$168.9M
Other Receivables	$41.90M	$41.96M	$35.50M
Total Short-Term Assets	$1.117B	$1.029B	$782.8M
YoY Change	39.27%	31.47%	24.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.098B	$1.089B	$977.4M
YoY Change	9.06%	11.37%	-3.82%
Goodwill	$703.8M	$704.0M
YoY Change	0.06%
Intangibles	$284.1M	$291.1M
YoY Change	-8.6%
Long-Term Investments
YoY Change
Other Assets	$25.11M	$25.90M	$29.54M
YoY Change	-18.53%	-12.32%	45.38%
Total Long-Term Assets	$2.111B	$2.109B	$2.032B
YoY Change	2.88%	3.83%	-1.92%
TOTAL ASSETS
Total Short-Term Assets	$1.117B	$1.029B	$782.8M
Total Long-Term Assets	$2.111B	$2.109B	$2.032B
Total Assets	$3.228B	$3.139B	$2.814B
YoY Change	13.11%	11.52%	4.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$130.5M	$117.1M	$198.9M
YoY Change	27.09%	-41.13%	108.84%
Accrued Expenses	$72.55M	$67.04M	$57.67M
YoY Change	2.81%	16.26%	10.06%
Deferred Revenue	$22.64M	$30.09M
YoY Change	-26.15%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.286M	$3.550M	$6.352M
YoY Change	-19.02%	-44.11%	5.22%
Total Short-Term Liabilities	$825.0M	$729.3M	$531.3M
YoY Change	46.69%	37.28%	21.55%
LONG-TERM LIABILITIES
Long-Term Debt	$1.426B	$1.425B	$1.353B
YoY Change	4.63%	5.31%	3.76%
Other Long-Term Liabilities	$32.20M	$30.61M	$35.24M
YoY Change	-7.79%	-13.12%	-41.95%
Total Long-Term Liabilities	$1.489B	$1.490B	$1.389B
YoY Change	4.2%	7.3%	-0.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$825.0M	$729.3M	$531.3M
Total Long-Term Liabilities	$1.489B	$1.490B	$1.389B
Total Liabilities	$2.314B	$2.219B	$1.944B
YoY Change	16.2%	14.14%	6.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$574.0M	-$583.2M
YoY Change	-10.25%
Common Stock	$25.00K	$25.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$913.4M	$919.5M	$870.1M
YoY Change
Total Liabilities & Shareholders Equity	$3.228B	$3.139B	$2.814B
YoY Change	13.11%	11.52%	4.14%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$9.180M	$11.61M	$13.62M
YoY Change	-485.39%	-14.78%	-110.53%
Depreciation, Depletion And Amortization	$54.60M	$55.44M	$54.62M
YoY Change	1.11%	1.5%	-10.61%
Cash From Operating Activities	-$1.600M	-$5.011M	$8.407M
YoY Change	-106.22%	-159.61%	-87.87%
INVESTING ACTIVITIES
Capital Expenditures	$79.60M	$101.2M	-$81.29M
YoY Change	-182.26%	-224.51%	49.54%
Acquisitions
YoY Change
Other Investing Activities	$36.90M	$38.27M	$37.06M
YoY Change	3.86%	3.25%	-102.83%
Cash From Investing Activities	-$42.70M	-$62.95M	-$44.23M
YoY Change	-30.27%	42.32%	-96.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.00M	77.77M	40.52M
YoY Change	-68.76%	91.96%	-96.93%
NET CHANGE
Cash From Operating Activities	-1.600M	-5.011M	8.407M
Cash From Investing Activities	-42.70M	-62.95M	-44.23M
Cash From Financing Activities	11.00M	77.77M	40.52M
Net Change In Cash	-33.30M	9.813M	4.692M
YoY Change	10177.78%	109.14%	-80.47%
FREE CASH FLOW
Cash From Operating Activities	-$1.600M	-$5.011M	$8.407M
Capital Expenditures	$79.60M	$101.2M	-$81.29M
Free Cash Flow	-$81.20M	-$106.2M	$89.70M
YoY Change	-166.3%	-218.42%	-27.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	248311104	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	248311104	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	131622000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	106654000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27869000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7378000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14360000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35902000	usd
	us-gaap	Interest Paid Net InterestPaidNet	56164000	usd
	us-gaap	Interest Paid Net InterestPaidNet	38417000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1450000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	575000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30000	usd
	ctos	Rental Equipment Sales In Accounts Receivable RentalEquipmentSalesInAccountsReceivable	2294000	usd
	ctos	Rental Equipment Sales In Accounts Receivable RentalEquipmentSalesInAccountsReceivable	1145000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	888443000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	342000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1122000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3374000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	904837000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	11610000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2222000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4008000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3205000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	919472000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	858510000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3273000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3272000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	858509000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	13623000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2636000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	629000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	870125000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q2	us-gaap	Revenues Revenues	456830000	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	141161000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	315669000	usd
CY2022Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	117083000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245023000	usd
CY2022Q2	us-gaap	Revenues Revenues	362106000	usd
CY2023Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	60500000	usd
CY2023Q2	ctos	Contract With Customer Other Receivable After Allowance For Credit Loss ContractWithCustomerOtherReceivableAfterAllowanceForCreditLoss	91500000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	168626000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16673000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151953000	usd
CY2023Q2	ctos	Contract With Customer Liability Current Deferred Rent ContractWithCustomerLiabilityCurrentDeferredRent	2600000	usd
CY2022Q4	ctos	Contract With Customer Liability Current Deferred Rent ContractWithCustomerLiabilityCurrentDeferredRent	3000000	usd
CY2023Q2	ctos	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	27500000	usd
CY2022Q4	ctos	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	29600000	usd
	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	27300000	usd
	ctos	Contract With Customer Timing ContractWithCustomerTiming	P1Y
	ctos	Contract With Customer Commission Benefit Period ContractWithCustomerCommissionBenefitPeriod	P1Y
CY2023Q2	ctos	Floor Plan Payables Trade Current FloorPlanPayablesTradeCurrent	139723000	usd
CY2022Q4	ctos	Floor Plan Payables Trade Current FloorPlanPayablesTradeCurrent	136634000	usd
CY2023Q2	ctos	Floor Plan Payables Non Trade Current FloorPlanPayablesNonTradeCurrent	366092000	usd
CY2022Q4	ctos	Floor Plan Payables Non Trade Current FloorPlanPayablesNonTradeCurrent	293536000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	8100000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	14900000	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	1397414000	usd
CY2022Q4	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	1360205000	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	476738000	usd
CY2022Q4	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	476531000	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	920676000	usd
CY2022Q4	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	883674000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1453811000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1389392000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	25144000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	27686000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	1428667000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1361706000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	3550000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6940000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1425117000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1354766000	usd
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29300000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23300000	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11610000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	246130000	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13623000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247745000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	825000	shares
CY2022Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	869000	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11610000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246955000	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	13623000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248614000	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	25410000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	246090000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10350000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247403000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	836000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	25410000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	246932000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10350000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248239000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000	usd
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	500000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	700000	shares
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3200000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4300000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2300000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.08
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2900000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.22
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q2	us-gaap	Revenues Revenues	456830000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	43616000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	346211000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	110619000	usd
CY2022Q2	us-gaap	Revenues Revenues	362106000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	43324000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	279348000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	82758000	usd
	us-gaap	Revenues Revenues	908993000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	83946000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	688713000	usd
	us-gaap	Gross Profit GrossProfit	220280000	usd
	us-gaap	Revenues Revenues	728582000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	88288000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	561331000	usd
	us-gaap	Gross Profit GrossProfit	167251000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	110619000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	82758000	usd
	us-gaap	Gross Profit GrossProfit	220280000	usd
	us-gaap	Gross Profit GrossProfit	167251000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58028000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48779000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	115019000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	102434000	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6606000	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6871000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	13278000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20206000	usd
CY2023Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	2721000	usd
CY2022Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	2317000	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	5371000	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	5364000	usd
CY2023Q2	ctos	Merger Related Costs MergerRelatedCosts	3689000	usd
CY2022Q2	ctos	Merger Related Costs MergerRelatedCosts	6046000	usd
	ctos	Merger Related Costs MergerRelatedCosts	7149000	usd
	ctos	Merger Related Costs MergerRelatedCosts	10694000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-31625000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20281000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-60801000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-39437000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5048000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15078000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8999000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24158000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12998000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13542000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27661000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13274000	usd
CY2023Q2	us-gaap	Assets Assets	3138644000	usd
CY2022Q4	us-gaap	Assets Assets	2938212000	usd

Files In Submission

Name	View Source	Status
0001709682-23-000048-index-headers.html	Edgar Link	pending
0001709682-23-000048-index.html	Edgar Link	pending
0001709682-23-000048.txt	Edgar Link	pending
0001709682-23-000048-xbrl.zip	Edgar Link	pending
a06302023ctosex311.htm	Edgar Link	pending
a06302023ctosex312.htm	Edgar Link	pending
a06302023ctosex32.htm	Edgar Link	pending
a102amendmentno1torevolvin.htm	Edgar Link	pending
a103amendmentno2torevolvin.htm	Edgar Link	pending
ctos-20230630.htm	Edgar Link	pending
ctos-20230630.xsd	Edgar Link	pending
ctos-20230630_cal.xml	Edgar Link	unprocessable
ctos-20230630_def.xml	Edgar Link	unprocessable
ctos-20230630_lab.xml	Edgar Link	unprocessable
ctos-20230630_pre.xml	Edgar Link	unprocessable
ctos-20230630_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTOS
Custom Truck One Source, Inc. Stock $ctos

2023 Q3 Form 10-Q Financial Statement

#000170968223000048 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTOS Custom Truck One Source, Inc. Stock $ctos

2023 Q3 Form 10-Q Financial Statement

#000170968223000048 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTOS
Custom Truck One Source, Inc. Stock $ctos